Navigation Links
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Date:4/21/2009

herapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials will not support approval for a marketing license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a marketing license has been applied, the risk that the results of a clinical trial may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 PuraMed BioScience®, Inc., (OTC Pink: PMBS), ... and healthcare products, announced it received the initial funding ... advanced headache relief product, for planned distribution to 1,000 ... , Washington State , and ... MigraPure H Advanced headache relief gel formulation completed, PuraMed ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
(Date:12/24/2014)... 23, 2014 In response to urgent requests from the ... Sierra Leone , Direct Relief delivered two 10-bed ... the treatment of local health workers who contract Ebola while ... Ebola care center was constructed for foreign health care workers ... available for local Sierra Leonean health workers. With ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... proposal now under consideration by the Medicare Payment Advisory ... services as part of a broader effort to fix ... of many clinical labs. That was the message of ... sent today to MedPAC Chairman Glenn Hackbarth. The letter ...
... 16, 2011 Many failing NHS hospitals across the ... billion rescue mission, according to a leading figure. Tony ... 40 trusts do not have enough money and therefore will need ... the Reform think tank, the professor argues that the NHS hospitals ...
Cached Medicine Technology:ACLA Voices Strong Concern Over MedPAC Proposal to Cut Medicare Reimbursement for Laboratory Services 2Failing NHS Hospitals in Need of a Business Rescue Plan 2
(Date:12/26/2014)... (PRWEB) December 26, 2014 India Network ... insurance in the USA, announced today a new version ... members in choosing the right plan for their visiting ... complexity out of the selection process when choosing an ... age group with only a few clicks. Many elderly ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... December 26, 2014 “Every three months the ... changes. A-line sweetheart evening dress will be one of the ... manager of Yunx.co.uk says. Today, the company releases 26 A-line ... up to 80% off. , “We are trying our ... style with our latest designs. Along with affordable prices, we ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 BambooFlooringChina.com sells ... high quality bamboo flooring. Today, the company announces ... in many styles and colors. , BambooFlooringChina.com is the ... CEO, the promotion is valid until Jan. 20, 2015. ... strips and woven with a natural thread. All the ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2
... standard part of testicular cancer care isnt used in ... condition, researchers at the University of Michigan Comprehensive Cancer ... one indicator of the presence of cancer cells, are ... with testis cancer, including diagnosis, prognostication and surveillance for ...
... 26-Week Study, WILMINGTON, Del., March 17 ... combination asthma therapy,SYMBICORT(R) (budesonide/formoterol fumarate dihydrate), in treating,persistent ... The study examined the,safety of SYMBICORT in children ... children previously treated with inhaled corticosteroid,either alone or ...
... Reduces Surgery Time, AUDUBON, Pa., March ... held spinal implant manufacturer in the world, ... Spacer System. The,new system significantly reduces the ... by offering an unprecedented array of,interoperative options. ...
... Kim Watson to Expand Global Partnerships for Clean Pesticide and Animal ... ... March 17 TyraTech (AIM:,TYR), a pioneer of safer, effective and ... markets, announced today,the appointment of Kim Watson as Senior Director Business ...
... March 17 Conseco, Inc. (NYSE:,CNO) today announced that ... to nominate two of its representatives to Conseco,s board ... strategic,alternatives and has engaged the investment banking firm of ... Prieur said, "We share with Steel Partners, as well ...
... SPRINGVILLE, Calif., March 17 Tropical Traditions,announced today that ... line. It is believed to be the first product ... made from the water inside of coconuts is a,cottage ... Water from,the inside of coconuts is highly valued due ...
Cached Medicine News:Health News:Testicular cancer gauge often not used 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 2Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 3Health News:Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma 4Health News:Globus Medical Launches NIKO(TM) Corpectomy Spacer System 2Health News:TyraTech Adds New Sr. Director Business Development 2Health News:TyraTech Adds New Sr. Director Business Development 3Health News:Tropical Traditions Announces New Organic Raw Coconut Water Vinegar 2
Angled shafts with 9 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle....
Curved shafts with fine pointed tips. Smooth handle with dull finish....
Medicine Products: